1. Executive Summary |
2. Global Structural Biology and Molecular Modelling Market Introduction |
2.1. Global Structural Biology and Molecular Modelling Market – Taxonomy |
2.2. Global Structural Biology and Molecular Modelling Market –Definitions |
2.2.1. Software Type |
2.2.2. Application |
2.2.3. Region |
3. Global Structural Biology and Molecular Modelling Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Structural Biology and Molecular Modelling Market Dynamic Factors - Impact Analysis |
3.6. Impact of COVID-19 on The Market |
3.7. Three Forecast Scenarios - Pessimistic, Conservative, and Opportunistic |
3.8. Mapping Market Players’ Activities |
3.9. Recent Key Developments |
3.10. Financial Status of the Market Players |
3.11. Recent Acquisitions, Collaborations, and Mergers |
4. Global Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Structural Biology and Molecular Modelling Market Forecast, By Software Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.1. Molecular Visualization |
5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Molecular Mechanics |
5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Semi-empirical Molecular Orbital |
5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Ab initio Molecular Orbital |
5.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Integrated Environments |
5.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Chemical Sketcher |
5.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Threading |
5.7.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
5.8. DNA & RNA Structure Predictor |
5.8.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.8.3. Market Opportunity Analysis |
5.9. Gene and Protein Sequence Alignment |
5.9.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.9.3. Market Opportunity Analysis |
5.10. Phylogenetic Search and Analysis |
5.10.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.10.3. Market Opportunity Analysis |
5.11. Crystallography and NMR |
5.11.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.11.3. Market Opportunity Analysis |
5.12. Genetic and Molecular Database Handling |
5.12.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.12.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.12.3. Market Opportunity Analysis |
5.13. Molecular Dynamics Simulations |
5.13.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.13.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.13.3. Market Opportunity Analysis |
5.14. Mathematical and Statistical Manipulation |
5.14.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.14.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.14.3. Market Opportunity Analysis |
5.15. Molecular Docking |
5.15.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.15.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.15.3. Market Opportunity Analysis |
5.16. Quantum Chemistry Calculation |
5.16.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.16.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.16.3. Market Opportunity Analysis |
5.17. Others |
5.17.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.17.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.17.3. Market Opportunity Analysis |
6. Global Structural Biology and Molecular Modelling Market Forecast, By Application, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.1. Small Molecule Drug Discovery |
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Biologics Drug Discovery |
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Drug Designing |
6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Drug-Receptor Interaction |
6.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Structural Biology and Molecular Modelling Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Distribution Channel, Application, and Region, 2022 - 2028 |
8. North America Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.1. Software Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
8.1.1. Molecular Visualisation |
8.1.2. Molecular Mechanics |
8.1.3. Semi-empirical Molecular Orbital |
8.1.4. Ab initio Molecular Orbital |
8.1.5. Integrated Environments |
8.1.6. Chemical Sketcher |
8.1.7. Threading |
8.1.8. DNA & RNA Structure Predictor |
8.1.9. Gene and Protein Sequence Alignment |
8.1.10. Phylogenetic Search and Analysis |
8.1.11. Crystallography and NMR |
8.1.12. Genetic and Molecular Database Handling |
8.1.13. Molecular Dynamics Simulations |
8.1.14. Mathematical and Statistical Manipulation |
8.1.15. Molecular Docking |
8.1.16. Quantum Chemistry Calculation |
8.1.17. Others |
8.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
8.2.1. Small Molecule Drug Discovery |
8.2.2. Biologics Drug Discovery |
8.2.3. Drug Designing |
8.2.4. Drug- Receptor Interaction |
8.2.5. Others |
8.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
8.3.1. U.S. |
8.3.2. Canada |
8.4. North America Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Application and Country, 2022 - 2028 |
8.5. North America Structural Biology and Molecular Modelling Market Dynamics – Trends |
9. Europe Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.1. Software Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
9.1.1. Molecular Visualisation |
9.1.2. Molecular Mechanics |
9.1.3. Semi-empirical Molecular Orbital |
9.1.4. Ab initio Molecular Orbital |
9.1.5. Integrated Environments |
9.1.6. Chemical Sketcher |
9.1.7. Threading |
9.1.8. DNA & RNA Structure Predictor |
9.1.9. Gene and Protein Sequence Alignment |
9.1.10. Phylogenetic Search and Analysis |
9.1.11. Crystallography and NMR |
9.1.12. Genetic and Molecular Database Handling |
9.1.13. Molecular Dynamics Simulations |
9.1.14. Mathematical and Statistical Manipulation |
9.1.15. Molecular Docking |
9.1.16. Quantum Chemistry Calculation |
9.1.16.1. Others |
9.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Small Molecule Drug Discovery |
9.2.2. Biologics Drug Discovery |
9.2.3. Drug Designing |
9.2.4. Drug- Receptor Interaction |
9.2.5. Others |
9.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Germany |
9.3.2. UK |
9.3.3. France |
9.3.4. Italy |
9.3.5. Spain |
9.3.6. Rest of Europe |
9.4. Europe Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Application and Country, 2022 - 2028 |
9.5. Europe Structural Biology and Molecular Modelling Market Dynamics – Trends |
10. Asia-Pacific Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
10.1. Software Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
10.1.1. Molecular Visualisation |
10.1.2. Molecular Mechanics |
10.1.3. Semi-empirical Molecular Orbital |
10.1.4. Ab initio Molecular Orbital |
10.1.5. Integrated Environments |
10.1.6. Chemical Sketcher |
10.1.7. Threading |
10.1.8. DNA & RNA Structure Predictor |
10.1.9. Gene and Protein Sequence Alignment |
10.1.10. Phylogenetic Search and Analysis |
10.1.11. Crystallography and NMR |
10.1.12. Genetic and Molecular Database Handling |
10.1.13. Molecular Dynamics Simulations |
10.1.14. Mathematical and Statistical Manipulation |
10.1.15. Molecular Docking |
10.1.16. Quantum Chemistry Calculation |
10.1.16.1. Others |
10.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Small Molecule Drug Discovery |
10.2.2. Biologics Drug Discovery |
10.2.3. Drug Designing |
10.2.4. Drug- Receptor Interaction |
10.2.5. Others |
10.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Japan |
10.3.2. China |
10.3.3. India |
10.3.4. ASEAN |
10.3.5. Rest of Asia-Pacific |
10.4. Asia-Pacific Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Application and Country, 2022 - 2028 |
10.5. Asia-Pacific Structural Biology and Molecular Modelling Market Dynamics – Trends |
11. Latin America Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
11.1. Software Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
11.1.1. Molecular Visualisation |
11.1.2. Molecular Mechanics |
11.1.3. Semi-empirical Molecular Orbital |
11.1.4. Ab initio Molecular Orbital |
11.1.5. Integrated Environments |
11.1.6. Chemical Sketcher |
11.1.7. Threading |
11.1.8. DNA & RNA Structure Predictor |
11.1.9. Gene and Protein Sequence Alignment |
11.1.10. Phylogenetic Search and Analysis |
11.1.11. Crystallography and NMR |
11.1.12. Genetic and Molecular Database Handling |
11.1.13. Molecular Dynamics Simulations |
11.1.14. Mathematical and Statistical Manipulation |
11.1.15. Molecular Docking |
11.1.16. Quantum Chemistry Calculation |
11.1.16.1. Others |
11.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Small Molecule Drug Discovery |
11.2.2. Biologics Drug Discovery |
11.2.3. Drug Designing |
11.2.4. Drug- Receptor Interaction |
11.2.5. Others |
11.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Brazil |
11.3.2. Argentina |
11.3.3. Rest of Latin America |
11.4. Latin America Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Application and Country, 2022 - 2028 |
11.5. Latin America Structural Biology and Molecular Modelling Market Dynamics – Trends |
12. Middle East and Africa Structural Biology and Molecular Modelling Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
12.1. Software Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
12.1.1. Molecular Visualisation |
12.1.2. Molecular Mechanics |
12.1.3. Semi-empirical Molecular Orbital |
12.1.4. Ab initio Molecular Orbital |
12.1.5. Integrated Environments |
12.1.6. Chemical Sketcher |
12.1.7. Threading |
12.1.8. DNA & RNA Structure Predictor |
12.1.9. Gene and Protein Sequence Alignment |
12.1.10. Phylogenetic Search and Analysis |
12.1.11. Crystallography and NMR |
12.1.12. Genetic and Molecular Database Handling |
12.1.13. Molecular Dynamics Simulations |
12.1.14. Mathematical and Statistical Manipulation |
12.1.15. Molecular Docking |
12.1.16. Quantum Chemistry Calculation |
12.1.16.1. Others |
12.2. Application Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Small Molecule Drug Discovery |
12.2.2. Biologics Drug Discovery |
12.2.3. Drug Designing |
12.2.4. Drug- Receptor Interaction |
12.2.5. Others |
12.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Saudi Arabia |
12.3.2. GCC Countries |
12.3.3. South Africa |
12.3.4. Rest of MEA |
12.4. MEA Structural Biology and Molecular Modelling Market - Opportunity Analysis Index, By Software Type, Application and Country, 2022 - 2028 |
12.5. MEA Structural Biology and Molecular Modelling Market Dynamics – Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Software Type Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Dassault Systèmes |
13.2.2. Agile Molecule |
13.2.3. Agilent Technologies, Inc. |
13.2.4. Acellera Ltd. |
13.2.5. ThermoFisher Scientific |
13.2.6. Schrodinger |
13.2.7. Affymetrix |
13.2.8. Bioinformatic LLC |
13.2.9. Biomax Informatics AG |
13.2.10. Bruker Daltonics Inc. |
13.2.11. Chemical Computing Group |
13.2.12. CLC bio |
13.2.13. Dassault Systemes |
13.2.14. Illumina |
14. Research Methodology |
15. Key Assumptions and Acronyms |
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.